Familial hypertrophic cardiomyopathy. Insertion-deletion polymorphism of angiotensin-converting enzyme and angiotensin II receptor;Rodzinna kardiomiopatia przerostowa. Polimorfizm insercyjno-delecyjny genu konwertazy angiotensyny oraz receptora dla angiotensyny II

Kardiologia Polska

Volumn 62, Issue 5, 2005, Pages 440-450

  Glanowska, Grazyna ^a,c,d   Domal Kwiatkowska, Dorota ^b   Smolik, Sławomir ^b   Wilczewski, Przemysław ^a,d   Szarek, Jarosław ^a,d   Nowalany Kozielska, Ewa ^a,d   Mazurek, Urszula ^b   Wodniecki, Jan ^a,d   Wilczok, Tadeusz ^b   Chojnowska, Lidia ^e  

^a Department of Cardiology ^*  (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c II Katedra i Oddział Kliniczny Kardiologii ^*  (Poland)

^d Katedra i Oddzia Kliniczny Laryngologii   (Poland)

^e INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Familial hypertrophic cardiomyopathy; Gene myosin; Polymorphism gene for ace and angiotensin 1 receptor

Indexed keywords

ADENINE; ANGIOTENSIN RECEPTOR; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCINE; LYSINE; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; EXON; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; MOTHER; PHENOTYPE; RECEPTOR GENE;

EID: 20444389752     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Erdmann J., Raible J., Maki-Abadi J. et al.: Spectrum of Clinical Phenotypes and Gene Variants in Cardiac Myosin - Binding Protein C Mutation Carriers With Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. 2001, 38, 322-30.
2. Roberts R., Sigwart U.: Kardiomiopatie przerostowe - nowe koncepcje, czȩść I. Circulation 2002, 1, 44-48.
3. Marian A.J., Roberts R.: The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2001, 33, 655-70.
4. Tendera M.: Kardiomiopatia przerostowa - złożona choroba sarkomeru. JACC-PL, 2002, rocz.3, nr 1.
5. Blair E., Redwood C., Ashrafian H.: Mutations in The γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Human Molecular Genetics, 2001, Vol. 10, No 11, 1215-1220.
6. Rigat B., Hubert C., AlhencaGelas F. et al.: Aninsertion/Deletion polymorhism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990, 86, 1343-1346.
7. Stepanov V.A., Puzyrev K.V., Spiridonova M.G. et al.: Polymorphism of angiotensin-converting enzyme and endothelial nitric oxide synthase genes in people with arterial hypertension, left ventricular hypertrophy, and hypertrophic cardiomyopathy. Genetika 1998, 34 (11), 1578-81.
8. Raynolds M.V., Brostow M.R., Bush E.W. et al.: Angiotensin-conwerting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342, 1073-9.
9. Gaciong Z., Religa P., Placha G.: Polimorfizm genetyczny w obrȩbie układu Renina- Angiotemsyna. Znaczenie dla rozwoju chorób układu kra̧żenia. Kardiol. Pol. 1998, 48, II- 39-43.
10. Ali J. Marian: On Genetic and Phenotypic Variability of Hypertrophic Cardiomyopathy: Nature Versus Nurture. J. Am. Coll. Cardiol. 2001, 38, 331-4.
11. Szunkert H., Hense H.W., Holmer S. et al.: Association between a deletion polymorphism of angiotensin converting enzyme gene and left ventricular hypertrophy. New Eng. J. Med. 1994, 330, 1634-8.